Hideyuki Saito
- Oncology top 0.2%
- Drug Transport and Resistance Mechanisms 86
- Biochemistry top 0.1%
- Amino Acid Enzymes and Metabolism 19
-
- Pharmacological Effects and Toxicity Studies 46
- Clinical Biochemistry top 0.2%
- Transplantation top 1%
-
- Antibiotics Pharmacokinetics and Efficacy 39
-
- Cancer therapeutics and mechanisms 23
- Ion Transport and Channel Regulation 20
-
- Antimicrobial Resistance in Staphylococcus 15
-
- Pregnancy and Medication Impact 14
- Co-authors
- Ken‐ichi InuiSatohiro MasudaMasahiro OkudaTomohiro TeradaYumiko UrakamiAkinobu HamadaYukiya HashimotoHiromi Tomioka
- Journals
- Journal of Pharmacology and Experimental Therapeutics (19 papers)Pharmaceutical Research (16 papers)Therapeutic Drug Monitoring (7 papers)
- Partner nations
- JapanUnited StatesRussia
In The Last Decade
Hideyuki Saito
256 papers receiving 9.2k citations
Peers
Comparison fields: 5 of 157
- Oncology 4.9k
- Biochemistry 1.3k
- Pediatrics, Perinatology and Child Health 2.6k
- Clinical Biochemistry 877
- Transplantation 316
Countries citing papers authored by Hideyuki Saito
This map shows the geographic impact of Hideyuki Saito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Saito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Saito more than expected).
Fields of papers citing papers by Hideyuki Saito
This network shows the impact of papers produced by Hideyuki Saito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Saito. The network helps show where Hideyuki Saito may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hideyuki Saito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 11 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 9 | |
| 5 | 2021 | 0 | |
| 6 | 2021 | 12 | |
| 7 | 2020 | 10 | |
| 8 | 2019 | 11 | |
| 9 | Emergency obstacle avoidance module for mobile robots using a laser range finder | 2013 | 2 |
| 10 | 2013 | 2 | |
| 11 | Immediate and Longitudinal Effects of Body Weight Support Treadmill Training for Patients with Chronic Hemiparesis After Stroke | 2011 | 2 |
| 12 | 2006 | 0 | |
| 13 | 2005 | 11 | |
| 14 | 2005 | 9 | |
| 15 | 2003 | 0 | |
| 16 | 2002 | 0 | |
| 17 | 2002 | 4 | |
| 18 | [Prolonged use of paclitaxel for platinum-refractory ovarian cancer--brief report]. | 2001 | 1 |
| 19 | 1997 | 17 | |
| 20 | [Antimycobacterial activity of a newly synthesized fluoroquinolone, Y-26611]. | 1992 | 4 |
About Hideyuki Saito
Hideyuki Saito is a scholar working on Oncology, Clinical Biochemistry and Biochemistry, having authored 273 papers that have together received 9.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (86 papers), Pharmacological Effects and Toxicity Studies (46 papers), Antibiotics Pharmacokinetics and Efficacy (39 papers), Cancer therapeutics and mechanisms (23 papers), Ion Transport and Channel Regulation (20 papers), Amino Acid Enzymes and Metabolism (19 papers), Antimicrobial Resistance in Staphylococcus (15 papers) and Pregnancy and Medication Impact (14 papers). The work is most often cited by research in Oncology (4.9k citations), Biochemistry (1.3k citations) and Pediatrics, Perinatology and Child Health (2.6k citations). Hideyuki Saito has collaborated with scholars based in Japan, United States and Russia. Frequent co-authors include Ken‐ichi Inui, Satohiro Masuda, Masahiro Okuda, Tomohiro Terada, Yumiko Urakami, Akinobu Hamada, Yukiya Hashimoto, Hiromi Tomioka, Hideyuki Motohashi and Maki Goto. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Pharmaceutical Research, Therapeutic Drug Monitoring, Biological and Pharmaceutical Bulletin and Drug Metabolism and Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.